Lung Cancer Therapeutics Market Size, Share, Growth Report 2030

Lung Cancer Therapeutics Market

Lung Cancer Therapeutics Market By Cancer Type (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), By Treatment (Immunotherapy, Chemotherapy, Targeted Therapy, Radiation Therapy, and Others), By Drug Class (Antimetabolites, Alkylating Agents, Mitotic Inhibitors, EGFR Inhibitors, Multikinase Inhibitors, and Others), By End-User (Hospitals, Homecare, Specialty Clinics, and Others), and By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Internet, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-4617 Published Date: Aug-2019 Status : Published

Global lung cancer therapeutics market is expected to generate around USD 42.24 billion by 2025, growing at a CAGR of around 13.2% between 2019 and 2025. Cancer is a disease caused by an uncontrolled division of abnormal cells in a part of the body. These extra cells slowly gather together to form a tissue mass called a tumor.

Lung Cancer Therapeutics Market

Lung Cancer Therapeutics Market: Overview

The report covers a forecast and an analysis of the lung cancer therapeutics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the lung cancer therapeutics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the lung cancer therapeutics market on a global and regional level.

In order to give the users of this report a comprehensive view of the lung cancer therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Lung Cancer Therapeutics MarketRequest Free Sample

The report provides a company market share analysis to give a broader overview of the key players in the lung cancer therapeutics market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the lung cancer therapeutics market on a global and regional basis.

The global lung cancer therapeutics market is segmented based on cancer type, treatment, drug class, end-user, distribution channel, and region. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some key players in the lung cancer therapeutics market are Hoffmann-La Roche, Eli Lilly and Company, Sanofi-Aventis, Pfizer, Celgene Corporation, GlaxoSmithKline, Boehringer Ingelheim, Agennix, AstraZeneca, and Merck & Co.

This report segments the global Lung cancer therapeutics market into:

Global Lung Cancer Therapeutics Market: By Cancer Type

  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)

Global Lung Cancer Therapeutics Market: By Treatment

  • Immunotherapy
  • Chemotherapy
  • Targeted Therapy
  • Radiation Therapy
  • Others

Global Lung Cancer Therapeutics Market: By Drug Class

  • Antimetabolites
  • Alkylating Agents
  • Mitotic Inhibitors
  • EGFR Inhibitors
  • Multikinase Inhibitors
  • Others

Global Lung Cancer Therapeutics Market: By End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Global Lung Cancer Therapeutics Market: By Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • Internet
  • Others

Global Lung Cancer Therapeutics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed